Adaptive Biotechnologies Corp at Goldman Sachs Healthcare Conference Transcript
Great. Good afternoon, everyone. Thanks for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs, and we're really pleased to have the Adaptive team with us. We have Chad Robins, CEO, Co-Founder and Chairman; and Tycho Peterson, CFO. Thank you, guys, for joining us.
Thanks, Salveen and Goldman, for having us. Appreciate it.
Questions & Answers
Yes. So maybe to start here, Tycho, you recently completed your first year as CFO of Adaptive and joining Chad. And Chad, you've kind of implemented, in conjunction with Tycho, this change in strategy here. So when we take a snapshot of where we are today versus last year and your outlook for the forward, with regard to the changes that you've taken, where are you from an implementation stage at this point? And are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |